RP Bio Inc. (KOSDAQ:314140)
South Korea · Delayed Price · Currency is KRW 5,950.00
+270.00 (4.75%)
At close: Jul 31, 2026
RP Bio Market Cap
RP Bio has a market cap or net worth of 51.56 billion as of July 31, 2026. Its market cap has decreased by -0.83% in one year.
Market Cap
51.56B
Enterprise Value
51.09B
Revenue
137.35B
Ranking
n/a
PE Ratio
9.19
Stock Price
5,950.00
ChartMarket Cap Chart
Since September 29, 2022, RP Bio's market cap has decreased from 143.18B to 51.56B, a decrease of -63.99%. That is a compound annual growth rate of -23.36%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2026 | 51.56B | -19.59% |
| Dec 30, 2025 | 64.13B | 46.53% |
| Dec 30, 2024 | 43.77B | -41.62% |
| Dec 28, 2023 | 74.96B | -26.88% |
| Dec 29, 2022 | 102.52B | -28.40% |
| Sep 29, 2022 | 143.18B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Polaris AI Pharma | 68.41B |
| Optipharm.CO.,LTD | 67.70B |
| GL Pharm Tech | 63.12B |
| Sinsin Pharmaceutical | 62.81B |
| BL Pharmtech | 61.68B |
| Pharos iBio | 61.30B |
| Sinil Pharmaceutical | 57.56B |
| Jin Yang Pharmaceutical | 49.32B |